NYSE · Medical Devices · USD
Inspire Medical Systems, Inc. (INSP) Stock Analysis
Inspire Medical Systems, Inc. (INSP) is a Medical Devices stock listed on NYSE and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
INSP Key Statistics
As of Oct 21, 2026Trading
- Open
- $70.84
- Previous Close
- $71.34
- Day's Range
- 70.41–72.44
- 52-Week Range
- 38.91–147.03
- Volume
- 554.25K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.73
Valuation
- Market Cap
- $2.05B
- P/E Ratio
- 15.65
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 46.26
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 2.29
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 4.54
Financials (FY)
- Revenue (FY)
- $911.98M+13.60%
- Net Income (FY)
- $145.42M+171.77%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 15.03%
- Shares Outstanding
- 28.91M
- 1-Year Return
- −14.16%
Dividend and dates
- Earnings Date
- November 2, 2026
- Avg Volume
- 801.87K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, INSP closed at $71.07, −14.16% over 1 year.
Inspire Medical Systems, Inc. (INSP) has a market capitalization of $2.05B.
In fiscal 2025, INSP reported revenue of $911.98M.
INSP Stock Return by Calendar Year
Inspire Medical Systems, Inc. (INSP) return since May 2018: what $10,000 became
- 1 year
- $10,000 $8,584
- −14.16%
- 5 years
- $10,000 $2,770
- −72.30%
- Since May 2018
- $10,000 $28,451
- +184.51%
If you had invested $10,000 in Inspire Medical Systems, Inc. (INSP) at the close on May 3, 2018, the earliest close on record here, it would have been worth $28,451 at the close on October 21, 2026: +184.51% in total, +13.14% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −22.94% |
| 2025 | −50.25% |
| 2024 | −8.87% |
| 2023 | −19.24% |
| 2022 | +9.48% |
| 2021 | +22.31% |
| 2020 | +153.46% |
| 2019 | +75.64% |
| 2018 (partial year) | +69.14% |
As of October 21, 2026.
INSP Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $911.98M | $145.42M | 15.9% |
| 2024 | $802.80M | $53.51M | 6.7% |
| 2023 | $624.80M | −$21.15M | −3.4% |
| 2022 | $407.86M | −$44.88M | −11.0% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $911.98M | $778.76M | $50.95M | $145.42M | 15.9% |
| 2024 | $802.80M | $679.82M | $36.08M | $53.51M | 6.7% |
| 2023 | $624.80M | $528.22M | −$40.27M | −$21.15M | −3.4% |
| 2022 | $407.86M | $341.74M | −$47.59M | −$44.88M | −11.0% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
INSP Valuation vs Medical Devices Median
Median of 145 stocks| Metric | INSP | Medical Devices median | vs median |
|---|---|---|---|
| P/E | 15.65 | 27.08 | 42% below |
| P/S ratio | 2.29 | 2.53 | 10% below |
| Profit margin | 15.03% | −14.78% | 29.8 pts above |
Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Truist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $78
BenzingaBarclays Initiates Coverage of Inspire Medical Systems at Underweight
FintelBarclays Initiates Coverage On Inspire Medical Systems with Underweight Rating, Announces Price Target of $65
BenzingaInspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026
YahooHow Investors Are Reacting To Inspire Medical Systems (INSP) Securing Category I CPT Codes For Inspire V
YahooMedical Devices & Supplies - Specialty Stocks Q2 Earnings Review: Inspire Medical Systems (NYSE:INSP) Shines
Yahoo
All 20 articles ↓Show fewer ↑
Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation
YahooInspire Medical (INSP): How Much Optimism Is Baked Into This Medtech Stock?
YahooInspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
YahooInspire Medical Systems Receives American Medical Association CPT Editorial Panel Approval To Establish New Set Of Current Procedural Terminology Codes
BenzingaRBC Capital Maintains Sector Perform on Inspire Medical Systems, Raises Price Target to $75
BenzingaInspire Medical Systems (INSP) Stock Could Be A Bargain On Cash Flow
YahooInspire Medical Systems (INSP) Faces A Rebound Question As Fair Value Stays In Focus
YahooHere's Why You Should Retain INSP Stock in Your Portfolio for Now
YahooFreedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97
BenzingaInspire Medical Systems (INSP) Stock Could Be 14% Undervalued On Cash Flow
YahooWhy Inspire Medical Systems (INSP) Stock Is Up Today
YahooStifel Maintains Buy on Inspire Medical Systems, Raises Price Target to $80
BenzingaInspire Medical Systems (INSP): Buy, Sell, or Hold Post Q2 Earnings?
YahooWhy Is Inspire (INSP) Down 4.1% Since Last Earnings Report?
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Medical Devices Stocks
Abbott Laboratories
$173.92B
MDTMedtronic plc.
$119.00B
SYKStryker Corporation
$114.15B
BSXBoston Scientific Corporation
$64.33B
EWEdwards Lifesciences Corporation
$50.95B
GEHCGE HealthCare Technologies Inc.
$31.17B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B














